Product Information
OXYBUTYNIN CL ER 5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0817 per EA under NDC 72888003005. Its NADAC has been published 85 times since Jan 8, 2025.
FDA first approved this application on Oct 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888003005
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214415FDA Approved
10/27/2020
TE Code
AB
On Market Since
10/27/2020
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 5 MG TABLET has been published 85 times since Jan 8, 2025, and over the history we have for it it has declined 4.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0817 per EA |
|---|---|
| All-time high | $0.1030 (Apr 16, 2025) |
| All-time low | $0.0817 (Aug 19, 2026) |
| 52-week high | $0.0990 |
| 52-week low | $0.0817 |
| Median price | $0.0950 |
| Average price | $0.0936 |
| Largest weekly change | +10.7% (Feb 19, 2025) |
| Weeks tracked | 85 |
| Tracking since | Jan 8, 2025 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0817 per EA (NDC 72888003005), effective Aug 19, 2026.
How has the price of OXYBUTYNIN CL ER 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has declined 4.2%. It has been tracked across 85 weekly CMS publications since Jan 8, 2025.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 5 MG TABLET?
Since Jan 8, 2025, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has ranged from a low of $0.0817 (Aug 19, 2026) to a high of $0.1030 (Apr 16, 2025), with a median of $0.0950 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 5 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYBUTYNIN 5 MG TABLET, is $0.0473 per EA — about 42% below OXYBUTYNIN CL ER 5 MG TABLET.
Who manufactures OXYBUTYNIN CL ER 5 MG TABLET?
OXYBUTYNIN CL ER 5 MG TABLET (NDC 72888003005) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.